Clinical Trial Update: ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control [NA]

View source ↗

Summary

A Taipei Veterans General Hospital-sponsored trial is evaluating an inhaled corticosteroid/long-acting beta-agonist inhaler with an integrated dose counter and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ICS/LABA inhaler with integrated dose counter

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Asthma | NA | Status: UNKNOWN